Literature DB >> 31089205

Biallelic variants in POLR3GL cause endosteal hyperostosis and oligodontia.

Paulien A Terhal1, Judith M Vlaar2, Sjors Middelkamp2, Rutger A J Nievelstein3, Peter G J Nikkels4, Jamila Ross5, Marijn Créton5, Jeroen W Bos6, Elsbeth S M Voskuil-Kerkhof7, Edwin Cuppen2, Nine Knoers8, Koen L I van Gassen9.   

Abstract

RNA polymerase III (Pol III) is an essential 17-subunit complex responsible for the transcription of small housekeeping RNAs such as transfer RNAs and 5S ribosomal RNA. Biallelic variants in four genes (POLR3A, POLR3B, and POLR1C and POLR3K) encoding Pol III subunits have previously been found in individuals with (neuro-) developmental disorders. In this report, we describe three individuals with biallelic variants in POLR3GL, a gene encoding a Pol III subunit that has not been associated with disease before. Using whole exome sequencing in a monozygotic twin and an unrelated individual, we detected homozygous and compound heterozygous POLR3GL splice acceptor site variants. RNA sequencing confirmed the loss of full-length POLR3GL RNA transcripts in blood samples of the individuals. The phenotypes of the described individuals are mainly characterized by axial endosteal hyperostosis, oligodontia, short stature, and mild facial dysmorphisms. These features largely fit within the spectrum of phenotypes caused by previously described biallelic variants in POLR3A, POLR3B, POLR1C, and POLR3K. These findings further expand the spectrum of POLR3-related disorders and implicate that POLR3GL should be included in genetic testing if such disorders are suspected.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31089205      PMCID: PMC6906301          DOI: 10.1038/s41431-019-0427-0

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  9 in total

1.  Functions of paralogous RNA polymerase III subunits POLR3G and POLR3GL in mouse development.

Authors:  Xiaoling Wang; Alan Gerber; Wei-Yi Chen; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-23       Impact factor: 11.205

2.  TAB2 deletions and variants cause a highly recognisable syndrome with mitral valve disease, cardiomyopathy, short stature and hypermobility.

Authors:  Aafke Engwerda; Erika K S M Leenders; Barbara Frentz; Paulien A Terhal; Katharina Löhner; Bert B A de Vries; Trijnie Dijkhuizen; Yvonne J Vos; Tuula Rinne; Maarten P van den Berg; Marc T R Roofthooft; Patrick Deelen; Conny M A van Ravenswaaij-Arts; Wilhelmina S Kerstjens-Frederikse
Journal:  Eur J Hum Genet       Date:  2021-08-30       Impact factor: 4.246

Review 3.  tRNA dysregulation and disease.

Authors:  Esteban A Orellana; Elisabeth Siegal; Richard I Gregory
Journal:  Nat Rev Genet       Date:  2022-06-09       Impact factor: 59.581

4.  MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass.

Authors:  Ellen Phillips; Naseer Ahmad; Li Sun; James Iben; Christopher J Walkey; Aleksandra Rusin; Tony Yuen; Clifford J Rosen; Ian M Willis; Mone Zaidi; Deborah L Johnson
Journal:  Elife       Date:  2022-05-25       Impact factor: 8.713

Review 5.  RNA Polymerases I and III in development and disease.

Authors:  Kristin En Watt; Julia Macintosh; Geneviève Bernard; Paul A Trainor
Journal:  Semin Cell Dev Biol       Date:  2022-04-11       Impact factor: 7.499

6.  Defective myelination in an RNA polymerase III mutant leukodystrophic mouse.

Authors:  Emilio Merheb; Min-Hui Cui; Juwen C DuBois; Craig A Branch; Maria Gulinello; Bridget Shafit-Zagardo; Robyn D Moir; Ian M Willis
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-05       Impact factor: 11.205

Review 7.  RNA polymerase III transcription as a disease factor.

Authors:  Meghdad Yeganeh; Nouria Hernandez
Journal:  Genes Dev       Date:  2020-07-01       Impact factor: 11.361

8.  Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery.

Authors:  Mostafa Saghi; Kolsoum InanlooRahatloo; Afagh Alavi; Kimia Kahrizi; Hossein Najmabadi
Journal:  BMC Med Genomics       Date:  2022-04-18       Impact factor: 3.622

9.  Combined Genome, Transcriptome and Metabolome Analysis in the Diagnosis of Childhood Cerebellar Ataxia.

Authors:  Ana Ching-López; Luis Javier Martinez-Gonzalez; Luisa Arrabal; Jorge Sáiz; Ángela Gavilán; Coral Barbas; Jose Antonio Lorente; Susana Roldán; Maria José Sánchez; Purificacion Gutierrez-Ríos
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.